ROWESTIL
CONSULTING



Provides experiential support & guidance for Translational Research (From Bench to Bedside) in the development of therapeutics and diagnostics for the biotech industry.








DEVELOPMENT PROGRAM STRATEGY


Starting with the correct development strategy is key. Completion of the appropriate background research to assess whether the scientific rationale meets the unmet medical need is fundamental for success including, but not limited to, the following:

  • Development of foundational building-block Target Product/Diagnostic Profiles for ~10 year time-horizons

  • Understanding the importance of constructive interactions with Regulatory Authorities to enable collaboration on development strategy

  • Maintaining rigorous scientific review of generated data with informed know-how on next steps


Rowestil Consulting can be contacted at the following email address:

rowestil@pm.me